V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219368 | 20083590 | 1.71 | 83 | Palliative (P) | 2019-02-04 | 2019-02-27 | null | null | N | CISPLATIN + ETOPOSIDE | 100323023 |
| 20219374 | 20083592 | 1.65 | 54 | null | 2019-07-30 | 2019-08-01 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 101121897 |
| 20219379 | 20083593 | null | null | null | 2018-01-31 | 2018-01-31 | LENVATINIB | 02 | null | LENVATINIB | 100588487 |
| 20219382 | 20083594 | null | 77 | Palliative (P) | 2016-05-22 | 2016-05-28 | null | null | N | LENVATINIB | 101847708 |
| 20219383 | 20083595 | 1.69 | 106 | Curative (C) | 2016-05-27 | 2016-05-31 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101358770 |
| 20219389 | 20083596 | 1.58 | 81 | Palliative (P) | 2016-04-07 | 2016-04-09 | null | null | null | HCX | 100561204 |
| 20219392 | 20083597 | 1.76 | 92 | Palliative (P) | 2018-06-22 | 2018-06-26 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 101419453 |
| 20219397 | 20083598 | 1.75 | 70.2 | Palliative (P) | null | 2019-12-12 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100653280 |
| 20219400 | 20083599 | 1.77 | 59.3 | Neo-adjuvant (N) | null | 2019-06-25 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101628008 |
| 20219403 | 20083600 | 1.65 | 47.8 | null | null | 2017-01-19 | null | null | Y | HCX | 100584316 |
| 20219407 | 20083601 | 1.73 | 66.7 | Neo-adjuvant (N) | 2017-09-19 | 2017-09-23 | ECarboX | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101485616 |
| 20219410 | 20083602 | 1.71 | 57.8 | Adjuvant (A) | 2019-05-16 | 2019-05-18 | null | null | N | CISPLATIN + ETOPOSIDE | 100152199 |
| 20219411 | 20083603 | 1.71 | 89 | Palliative (P) | null | 2017-12-04 | null | null | N | HCX | 100938377 |
| 20219412 | 20083604 | 1.65 | 87.3 | Neo-adjuvant (N) | 2020-01-11 | 2020-01-13 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101166771 |
| 20219415 | 20083607 | 1.69 | 58.4 | Curative (C) | 2016-10-26 | 2016-11-15 | CAPECITABINE + CISPLATIN + Trastuzumab | N | Y | HCX | 101564376 |
| 20219416 | 20083608 | 1.65 | 77.9 | Palliative (P) | 2016-12-19 | 2017-01-01 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101466062 |
| 20219419 | 20083609 | null | null | null | 2017-06-09 | 2017-06-09 | CETUXIMAB + IRINOTECAN + MDG | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 101583039 |
| 20219423 | 20083610 | 1.69 | 83 | Palliative (P) | 2018-03-06 | 2018-04-06 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | CETUXIMAB + IRINOTECAN + MDG | 100262703 |
| 20219427 | 20083611 | 1.59 | 61.2 | Neo-adjuvant (N) | null | 2016-10-31 | null | null | N | HCX | 101423756 |
| 20219430 | 20083612 | 1.58 | 65 | Palliative (P) | 2018-06-12 | 2018-06-12 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101855761 |
| 20219432 | 20083613 | 1.85 | 75.9 | null | 2017-09-04 | 2017-09-05 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 2 | Y | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100092970 |
| 20219434 | 20083615 | 1.6 | 65 | Palliative (P) | null | 2019-03-24 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101703923 |
| 20219435 | 20083616 | null | 130 | Palliative (P) | 2019-03-06 | 2019-03-11 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101718338 |
| 20219436 | 20083617 | 1.52 | 52.1 | Curative (C) | null | 2017-05-05 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101496915 |
| 20219443 | 20083618 | 1.81 | 75.4 | Palliative (P) | null | 2017-09-10 | Cape+Cisplatin+Trastuzumab Load | N | null | HCX | 100617489 |
| 20219446 | 20083619 | null | null | null | null | 2018-07-13 | null | null | null | CISPLATIN + ETOPOSIDE | 100922353 |
| 20219451 | 20083621 | null | null | null | 2018-09-21 | 2018-09-21 | null | null | null | CISPLATIN + ETOPOSIDE | 100439657 |
| 20219458 | 20083623 | 1.62 | 60.8 | Curative (C) | null | 2017-08-14 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 101127911 |
| 20219459 | 20083624 | null | null | null | null | 2017-02-04 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101791596 |
| 20219463 | 20083625 | 1.73 | 79.2 | Neo-adjuvant (N) | 2017-05-01 | 2017-05-01 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101815784 |
| 20219469 | 20083626 | 1.7 | 96.8 | Palliative (P) | 2019-11-21 | 2019-11-21 | null | null | N | HCX | 100224647 |
| 20219479 | 20083629 | 1.85 | 0 | Palliative (P) | 2018-09-12 | 2018-09-20 | null | null | N | CAPECITABINE + IRINOTECAN | 101624067 |
| 20219484 | 20083630 | null | null | null | null | 2016-04-22 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101551432 |
| 20219489 | 20083633 | null | null | null | 2017-02-10 | 2017-02-23 | LENVATINIB | 02 | null | LENVATINIB | 100051231 |
| 20219493 | 20083634 | 1.79 | 71.8 | Palliative (P) | null | 2018-08-15 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100051411 |
| 20219497 | 20083635 | null | null | null | null | 2016-06-02 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101202280 |
| 20219498 | 20083636 | 1.76 | 83 | Palliative (P) | 2019-08-01 | 2019-08-08 | LENVATINIB | 99 | N | LENVATINIB | 100292557 |
| 20219502 | 20083638 | 1.7 | 80 | Palliative (P) | 2017-05-04 | 2017-05-16 | ECarboX | 02 | N | CAPECITABINE + IRINOTECAN | 100917502 |
| 20219514 | 20083641 | 1.74 | 84.3 | Palliative (P) | 2018-03-22 | 2018-03-22 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101588929 |
| 20219515 | 20083642 | null | null | null | null | 2017-10-14 | null | null | null | LENVATINIB | 100964114 |
| 20219516 | 20083643 | 1.81 | 70 | Curative (C) | null | 2018-01-09 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100562788 |
| 20219519 | 20083644 | null | null | null | 2017-05-21 | 2017-05-28 | LENVATINIB | 02 | null | LENVATINIB | 101348866 |
| 20219521 | 20083645 | 1.7 | 59.8 | Palliative (P) | null | 2018-05-22 | null | null | N | LENVATINIB | 101323470 |
| 20219523 | 20083646 | null | null | null | 2018-10-15 | 2018-10-17 | null | null | null | CAPECITABINE + IRINOTECAN | 100410698 |
| 20219524 | 20083647 | 1.8 | 102 | Adjuvant (A) | null | 2018-08-06 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100129783 |
| 20219525 | 20083648 | null | null | null | 2017-10-28 | 2017-10-29 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100179100 |
| 20219529 | 20083650 | 1.75 | 72.8 | Palliative (P) | 2017-11-25 | 2017-11-27 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100043388 |
| 20219532 | 20083651 | 1.58 | 98.8 | null | 2018-06-07 | 2018-06-15 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101503050 |
| 20219534 | 20083652 | 1.61 | 68.2 | Adjuvant (A) | 2019-11-13 | 2019-11-15 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101206885 |
| 20219535 | 20083653 | null | null | null | 2016-03-30 | 2016-03-31 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100715724 |